• News

  • Who are we?

    • Management
    • Board of directors

  • Our project

  • More...

    Use tab to navigate through the menu items.
    View our research
    Contact us
    Open Site Navigation
    TIR-C selected for IVA's 100 list
    • 17 maj

    TIR-C selected for IVA's 100 list

    TIRmed Pharma consortium receives grant of 1.5 MSEK from Vinnova
    • 27 apr.

    TIRmed Pharma consortium receives grant of 1.5 MSEK from Vinnova

    TIRmed Pharma initiates permeability study with leading CRO
    • 12 sep. 2021

    TIRmed Pharma initiates permeability study with leading CRO

    TIRmed Pharma raises 5.4 MSEK in equity for pre-clinical development
    • 19 nov. 2020

    TIRmed Pharma raises 5.4 MSEK in equity for pre-clinical development

    New publication
    • 15 okt. 2020

    New publication

    TIRmed Pharma receives approval to grant patents in Europe
    • 17 juni 2020

    TIRmed Pharma receives approval to grant patents in Europe

    TIRmed Pharma receives approval of patent in the US
    • 11 maj 2020

    TIRmed Pharma receives approval of patent in the US

    TIRMED PHARMA

    Our latestnews

    © 2023 by TIRmed Pharma - Draft by Ensotech AB

    © 2022 TIRmed Pharma AB - Powered by Ensotech AB

    leo.holmgren@tirmedpharma.com  |  Tel: +46 70 049 18 42  |  Alviksvägen 11 67 53 Stockholm

    • Vit Edin Ikon
    • Annual reports
    • News
    • Who are we?
      • Management
      • Board of directors
    • Our project
    • Contact us